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We have attempted to evaluate the effect on the hypertensive 
heart of betablockers/BB analyzing the change and interrelations of 
arterial blood perssure (ABP), left ventricular hypertrophy ( L V H ) and 
function ( L V F ) . A total of 190 patients with essential hyperten­
sion ( E H ) were treated for 12 months with different classes of BB 
(monoterapy). By means of M-mode echocardiography and semi­
automatic analysis of the recordings performed before and at the end 
of the 1 s t , 6 t h and 12 t h month of treatment the following parameters 
were assessed: left ventricular muscle mass (LVMM), the ratio sys­
tolic ABP/end-systolic volume of the LV (ABP S /ESVIV) , maximal rate 
of augmentation of L V diameter during the fast filling peri­
od ( + dD/dtmax F F P ) and maximal rate of augmentation of L V 
diameter during stria! contraction ( + dD/dtmax АС). The A B P S / E S V L V 
in hypertensive patients without L V H is not different than in normals 
(4,36 ± 1,04 vs 4,31 ±0,67, p>0,10) whereas in patients with L V H it 
is lower (4,01 ± 0,72, p< 0,045). There is a positive, though moder­
ate, but still significant correlation (r = 0,474, p< 0.001, n = 74) be­
tween L V M M and ABPs/ESVLV in patients without L V H and those with 
L V M M within the limit of 4 SD above the mean normal value. For the 
whole group of patients with L V H , however, the correlation is nega­
tive and significant by all means (r = -0,653, p<0,001). The 
+ dD/dtmax FFP in patients without L V H is lower than in normals (14,6 
±3,3 cm.s vs 16,8 ±1,90, p< 0,001) and in patients with L V H there 
is additional reduction (12,6 ± 2,0, p<0,001). The changes in 
+ dD/dtmax AC are reciprocal (4,0 ± 0,5 cm.s" in normals; 5,2 * itQ 
in patients without L V H , p< 0,0001; 5,6 ± 0,9 in patients with L V H , 
p<0,045). There exist a moderate negative correlation between 
L V M M and + dD/dtmax F F P (r =-0,480, p<0,01) as well as a moderate 
positive between L V M M and + dD/dtmax AC (r = 0,449, p< 0,001). 
There is a significant correlation between percentage reduction 
of ABPS (r = 0,603, p< 0,001) and heart rate (r = 0,636, p< 0,001) and 
that of L V M M ; for ABPd the correlation is moderate ( r ~ 0 , 4 5 7 
p< 0,001). The reduction of L V M M is greater with BB without ISMA 
(p = 0,02 for the 6 t h month and p< 0,001 for the 12 t h month). 
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Table 1. ABPg, ABPd , LVMM and LVF during BB therapy in 
hypertensive patients with LVH 
Indices Initial 1st m o n t h 6 t n month 1 2 m o n t h 
ABPS 156,5*14,2 141,5*13,7- 134,8*11,9+ 132,6*11,8 
ABPd 106,4* 8,5 90,7* 8,6- 89,4* 7,9+ 88,8*7,3 
LVMM 278,9*36,6 269,5*32,3 225,5*29,0+ 214,5*29,9 
ABP^/ESVLV 4ti±0,98 3,7*0,81- 3,9*0,88 4,0*1,0 
+dD/dtmaxFFP 12,6*3,8 14,1*3,9- 15,2*2,7+ 15,7*2.7* 
«U>/*tmaxAC 5>s±0>7 5,0*0,7- 4,5*0,5+ 4,4*0,6 
. compares "lnitial-1st month" + compares " 1 s t month-6 th month" 
* compares "6 t h month-12 tb month" 
Cardioselectivity has no impact on LVH-regression.Our results 
show that in hypertensive heart disease the adaptative increase of 
muscle mass is combined with the transition towards the so-called 
"slow type muscle" which allows managing with the increased after-
load but leads to specific unfavourable consequences. There is re-
tarded relaxation and a contractile deficit that advances with LVMM 
increase. The process is slow and takes place generally between the 
1 e t and 6 month of treatment. Regression of LVH is defined by 
multiple factors with the leading role of ABP-control and adrenergic 
cardiostimulation reduction. Relying to that, LVH-regression is more 
pronounced when BB without ISMA are used. The end-point effect of 
chronic BB therapy upon systolic and diastolic function in hypertens-
ive heart is favourable. The reduced LV afterload and LVH-regression 
succeed not only to compensate for the direct negative effect of BBs 
on myocardial contractility and relaxation but also to actually bring 
forth an additional improvement of ventricular function. In that re-
spect there is no principal difference for the various clases of BBs. 
The quantitative differences of the negative inotropic effect of BBs 
with and without ISMA can be still of practical importance in the in-
itial treatment of patients with pronounced LVH in whom there is a 
concealed contractile deficit. Later, however, the greater degree of 
regression of LVH in BBs without ISMA leads to an equal end-effect 
of BBs with or without ISMA upon ventricular function. Cardioselec-
tivity has no impact on hitherto described functional changes. 
